$XNET

Xunlei (XNET) Q2 2025 Earnings Call Transcript

Image source: The Motley Fool.Thursday, August 14, 2025 at 8:00 a.m. ETChairman and CEO - Jinbo LiContinue reading ...

Original reporting
Motley Fool · Motley Fool Transcribing
Published Aug 14, 2025, 1:58 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 15, 2025, 12:32 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Xunlei (XNET) Q2 2025 Earnings Call Transcript — source image
Decision brief

The 30-second read

$XNETBullishMed
01

Why it matters

The positive earnings report suggests operational improvements and potential for increased investor confidence.

02

Market read

The earnings call provides valuable insights for investors interested in Chinese tech stocks, with moderate impact on related sectors.

03

What to watch

Regulatory risks and competitive pressures in the Chinese internet sector could offset positive earnings impact.

Timing: High, as earnings reports directly influence stock movements within days.

Background

Xunlei is a Chinese internet company specializing in cloud computing and digital content services.

Company-level read

Ticker impact

$XNETBullishMedium confidence
Context

The earnings call transcript provides insights into Xunlei's financial performance and strategic direction for Q2 2025.

Expected impact

Moderate upward movement in the short term, potential for sustained growth if trends continue.

Evidence & confidence

Financial metrics are favorable, but market reaction depends on broader tech sector conditions and investor sentiment.

Market effects

Positive sentiment may boost related tech and internet service stocks.

Potential uplift in Asian tech markets, especially in China.

Limited, as Xunlei primarily operates domestically with niche services.

Counterpoint

Earnings optimism may be already priced in; any disappointment could lead to sharp declines.

Key entities

  • Xunlei Limited

    A Chinese internet company providing cloud computing, digital content, and online services.

  • Jinbo Li

    Chairman and CEO of Xunlei, leading strategic initiatives.

Related articles

$XNETMedAI 8/10

Xunlei (XNET) Q2 2026 Earnings Call Transcript

Xunlei (XNET) reported Q2 2026 results in an earnings call transcript. Total revenue rose to $102.7 million, up 38.9% year over year, driven by subscription revenue of $44.5 million (+22.6%) and overseas audio live streaming revenue of $58.2 million (+54.8%). Gross margin fell to 55.8% from 63%. The company announced a $20 million share repurchase program.

$XNETMedAI 8/10

Xunlei Limited: Xunlei Announces Unaudited Financial Results for the Second Quarter Ended June 30, 2026

Xunlei Limited (Nasdaq: XNET) reported unaudited Q2 2026 results for the quarter ended June 30, 2026. Total revenues were $102.7M (+38.9% YoY), with subscription $44.5M (+22.6%) and live-streaming/other $58.2M (+54.8%). Gross profit was $57.3M (margin 55.8% vs 63.0%). Net loss from continuing ops was $218.5M ($3.43 loss per ADS); non-GAAP net loss was $2.1M. The company also announced a new share repurchase program.

$XNETMedAI 9/10

Xunlei Announces Unaudited Financial Results for the First Quarter Ended March 31, 2026

Xunlei Limited (Nasdaq: XNET) reported unaudited Q1 2026 results for the quarter ended March 31, 2026. Total revenue rose 54.1% YoY to $98.6m, driven by subscription ($45.0m, +26.2%) and overseas audio live-streaming ($53.6m, +89.3%). Gross profit increased to $57.7m, but margin fell to 58.5%. Net loss from continuing operations was $192.4m; non-GAAP net income was $4.1m.

$HNGEMed

Jim Cramer says one stock hitting new highs is still a screaming buy

Jim Cramer reiterated a triple buy call on Hinge Health (HNGE) on “Mad Money” Aug. 11. The stock hit a new all-time high of $93.13 on Aug. 10 and is up about 85.83% YTD, per Yahoo Finance. Hinge reported Q2 2026 revenue of $213 million (+53% YoY), free cash flow of $99.6 million, and raised FY guidance to $856-$860 million. It also agreed to a $105 million cash acquisition (Cylinder Health) to expand into GI care.